Male Birth Control: A New Frontier

Introduction to NES/T Gel

The pursuit of male birth control is gaining momentum, shifting the focus from traditional female contraceptives to innovative male options. Recent phase II clinical trials have revealed promising results for NES/T, an alcohol-based gel reminiscent of aftershave, which combines testosterone and nestosterone to effectively and reversibly suppress sperm production.

Progressing to Phase IIb Trials

As NES/T advances to phase IIb clinical trials, scientists from the U.S. government express optimism about its potential to become a viable male contraceptive solution. Developed by researchers at the National Institute of Child Health and Human Development (NICHD) and the Population Council, this hormonal treatment achieves sperm counts of 1 million or fewer sperm per milliliter of semen, which is deemed effective for contraception. The gel is absorbed through the skin, allowing hormones to enter the bloodstream and exert their effects.

Historical Significance of NES/T

NES/T is notable for being the first male contraceptive gel to progress beyond initial clinical trials. Early phase IIb results have been encouraging, with couples reporting successful pregnancies after ceasing the use of the gel, indicating its reversibility.

Effectiveness of the Gel-on Method

Trial Details and Results

In the phase II trial, 222 men applied the gel daily to their shoulders and arms over a 52-week period. Researchers monitored sperm counts every four weeks, defining effective contraception as having a count of 1 million or fewer sperm per milliliter. Remarkably, after just 12 weeks, 86% of participants achieved sufficient sperm suppression, highlighting an advancement over previous hormonal male contraceptive attempts, which often resulted in higher dosages and unwanted side effects.

Unique Hormonal Combination

The gel’s success is attributed to its innovative combination of testosterone and Nestorone, a synthetic hormone already utilized in female contraceptives. This formulation allows for lower testosterone levels, effectively minimizing side effects while preserving normal sexual function.

Next Steps in Research

Phase IIb Study Overview

The next phase of the trial focuses on the gel’s efficacy in preventing pregnancy. The Phase IIb study will involve 420 couples across 15 sites, structured in four phases: an initial screening phase, a 20-week suppression phase where men will use the gel daily until their sperm count reaches targeted low levels, followed by a year-long evaluation phase, and concluding with a 24-week recovery phase to observe sperm count normalization post-treatment.

Participant Monitoring and Support

Throughout the trial, male participants will apply the NES/T gel daily and attend monthly check-ins for monitoring. Their female partners will also receive monthly contacts, with in-person visits scheduled every three months.

Challenges and Future Prospects

Funding and Research Hurdles

Despite decades of research, the absence of federally approved male contraceptives underscores the challenges faced in securing funding for large-scale trials. Nevertheless, experts remain hopeful that the success of NES/T and similar initiatives will pave the way for expanded reproductive options for men.

Expert Insights

Dr. Diana Blithe, chief of the Contraceptive Development Program at the National Institutes of Health (NIH), emphasized the critical need for a safe and effective male contraceptive, stating, “The development of a safe, highly effective and reliably reversible contraceptive method for men is an unmet need.” She acknowledged that while some hormonal agents have shown potential, their slow onset of spermatogenic suppression has been a limitation.

Trial Goals and Importance

As the current phase of the international trial continues to demonstrate the gel’s effectiveness in suppressing sperm production, researchers are now assessing its contraceptive effectiveness, safety, user tolerance, and the reversibility of its effects post-treatment. This endeavor not only aims to provide men with more contraceptive choices but also seeks to empower couples in their family planning decisions.

Conclusion

As research progresses, the potential of male hormonal birth control is on the horizon, with NES/T leading the charge. The future of birth control may soon lie in men’s hands—or, more accurately, on their shoulders.

References

Study of Daily Application of Nestorone® (NES) and Testosterone (T) Combination Gel for Male Contraception (no date) Clinicaltrials.gov. Available at: https://clinicaltrials.gov/study/NCT03452111 (Accessed: 13 September 2024).
Spotlight: One Year and counting: Male birth control study reaches milestone (no date) Eunice Kennedy Shriver National Institute of Child Health and Human Development. Available at: https://www.nichd.nih.gov/newsroom/news/080222-NEST (Accessed: 13 September 2024).
Endocrine Society (2024) New male birth control gel takes effect sooner than similar contraceptive methods, Endocrine Society. Available at: https://www.endocrine.org/news-and-advocacy/news-room/2024/endo-2024-press-blithe (Accessed: 23 September 2024).